Compass Therapeutics (CMPX) Prepaid Assets (2019 - 2026)
Compass Therapeutics (CMPX) posted Prepaid Assets of $1.0 million for Q1 2026, up 9.53% sequentially from $913000.0 in Q4 2025, and down 91.31% YoY from $11.5 million in Q1 2025.
Compass Therapeutics (CMPX) Prepaid Assets (2019 - 2026) Analysis & Trends
Compass Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $1.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 91.31% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 91.31% YoY) and the FY2025 annual result came in at $913000.0, down 84.86% from the prior year.
- Prepaid Assets improved to $1.0 million in Q1 2026 per CMPX's latest filing, from $913000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $11.5 million in Q1 2025 and troughed at $913000.0 in Q4 2025.
- A 5-year average of $4.5 million and a median of $3.9 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets soared 388.54% in 2025, then plunged 91.31% in 2026.
- Over 5 years, Prepaid Assets stood at $8.2 million in 2022, then sank by 82.64% to $1.4 million in 2023, then soared by 324.58% to $6.0 million in 2024, then slumped by 84.86% to $913000.0 in 2025, then grew by 9.53% to $1.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.0 million, $913000.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 913,000.00 |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 5.25 Mn |
| Mar 31, 2025 | 11.51 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 2.88 Mn |
| Jun 30, 2023 | 6.52 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 3.06 Mn |